Literature DB >> 34541234

Preparation of Primary Astrocyte Culture Derived from Human Glioblastoma Multiforme Specimen.

Mansoureh Hashemi1, Mahmoudreza Hadjighassem2,3.   

Abstract

Glioblastoma multiforme (GBM) is a grade 4 astrocytoma tumor in central nervous system. Astrocytes can be isolated from human GBM. Study of astrocytes can provide insights about the formation, progression and recurrence of glioblastoma. For using isolated astrocytes, new studies can be designed in the fields of pharmacology, neuroscience and neurosurgery for glioblastoma treatment. This protocol describes the details for preparing high purity primary astrocytes from human GBM. Tumor tissue is disrupted using mechanical dissociation and chemical digestion in this protocol. 2 weeks after plating the cell suspension in culture, primary astrocytes are available for further subculturing and immunocytochemistry of S100-beta antigen.
Copyright © 2017 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  Astrocyte; Astrocytoma tumor; Glioblastoma multiforme; Malignant brain tumor; Primary cell culture; S100-beta antigen

Year:  2017        PMID: 34541234      PMCID: PMC8410322          DOI: 10.21769/BioProtoc.2241

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  3 in total

Review 1.  Malignant gliomas in adults.

Authors:  Patrick Y Wen; Santosh Kesari
Journal:  N Engl J Med       Date:  2008-07-31       Impact factor: 91.245

2.  A New Approach in Gene Therapy of Glioblastoma Multiforme: Human Olfactory Ensheathing Cells as a Novel Carrier for Suicide Gene Delivery.

Authors:  Mansoureh Hashemi; Ali Fallah; Hamid Reza Aghayan; Babak Arjmand; Nasrin Yazdani; Javad Verdi; Seyed Mohammad Ghodsi; Seyed Mojtaba Miri; Mahmoudreza Hadjighassem
Journal:  Mol Neurobiol       Date:  2015-09-22       Impact factor: 5.590

3.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

Authors:  Roger Stupp; Warren P Mason; Martin J van den Bent; Michael Weller; Barbara Fisher; Martin J B Taphoorn; Karl Belanger; Alba A Brandes; Christine Marosi; Ulrich Bogdahn; Jürgen Curschmann; Robert C Janzer; Samuel K Ludwin; Thierry Gorlia; Anouk Allgeier; Denis Lacombe; J Gregory Cairncross; Elizabeth Eisenhauer; René O Mirimanoff
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.